Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
NIH-logos NIGMS Logo NIAAA Logo NCI Logo NIH Logo
Protein Page:
FGFRL1 (human)

FGFRL1 Has a negative effect on cell proliferation. Note: This description may include information from UniProtKB.
Protein type: Membrane protein, integral
Cellular Component: plasma membrane; integral to membrane
Molecular Function: heparin binding; fibroblast growth factor binding; fibroblast growth factor receptor activity
Biological Process: negative regulation of cell proliferation; fibroblast growth factor receptor signaling pathway; skeletal development
Reference #:  Q8N441 (UniProtKB)
Alt. Names/Synonyms: FGF homologous factor receptor; FGF receptor-like protein 1; FGFR-5; FGFR-like protein; FGFR5; FGFRL1; FGRL1; FHFR; Fibroblast growth factor receptor 5; Fibroblast growth factor receptor-like 1
Gene Symbols: FGFRL1
Molecular weight: 54,537 Da
Basal Isoelectric point: 9.79  Predict pI for various phosphorylation states
Select Structure to View Below


Protein Structure Not Found.

STRING  |  Scansite  |  Phospho.ELM  |  Pfam  |  Source  |  InnateDB  |  GeneCards  |  UniProtKB  |  Entrez-Gene  |  GenPept  |  Ensembl Gene

Modification Sites and Domains  

Modification Sites in Parent Protein, Orthologs, and Isoforms  

Show Multiple Sequence Alignment


SS: The number of records in which this modification site was determined using site-specific methods. SS methods include amino acid sequencing, site-directed mutagenesis, modification site-specific antibodies, specific MS strategies, etc.


MS: The number of records in which this modification site was assigned using ONLY proteomic discovery-mode mass spectrometry.


0 4 Y502-p KVHQHIHyQC_____

- gap
Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.